| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | — |
| R&D Expense | $17.4M | -40.9% |
| SG&A Expense | $18.4M | -29.4% |
| Operating Income | -$28.4M | +47.8% |
| Interest Expense | $2.9M | -31.0% |
| Pre-tax Income | -$30.0M | +30.1% |
| Income Tax | -$532K | +25.9% |
| Net Income | -$29.5M | +30.2% |
| EPS (Basic) | -$0.04 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.4M | -15.8% |
| Current Assets | $63.8M | -15.2% |
| Total Assets | $66.5M | -14.1% |
| Current Liabilities | $9.5M | -61.1% |
| Total Liabilities | $16.0M | -38.6% |
| Stockholders' Equity | $50.5M | -1.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.1M | +56.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$419K | -121.1% |
| Financing Cash Flow | $8.0M | +3886.5% |
| Free Cash Flow | -$21.1M | +56.7% |
| +42.9% |
| EPS (Diluted) | -$0.04 | +42.9% |